Document is current

Any future updates will be listed below

Metastasiertes Nierenzellkarzinom: TKI-Monotherapie bei Good-Risk-Patienten

Crossref DOI link: https://doi.org/10.1007/s00092-024-6513-9

Published Online: 2025-01-08

Published Print: 2025-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark